{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:21:45Z","timestamp":1785928905803,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejmech.2019.05.081","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:37:38Z","timestamp":1559255858000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-5815","authenticated-orcid":false,"given":"Dmitry A.","family":"Maslov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Korotina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill V.","family":"Shur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A.","family":"Vatlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga B.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana G.","family":"Tolshchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashida I.","family":"Ishmetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina K.","family":"Ignatenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady L.","family":"Rusinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery N.","family":"Charushin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery N.","family":"Danilenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.05.081_bib1","series-title":"Global Tuberculosis Report 2017, Geneva","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.ejmech.2019.05.081_bib2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.081_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.081_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/\/EID1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"19","author":"Klopper","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.081_bib5","first-page":"307","article-title":"The totally drug resistant tuberculosis (TDR-TB)","volume":"6","author":"Velayati","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2019.05.081_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s12272-009-1701-4","article-title":"Novel facile synthesis of imidazo[1,2-b]-[1,2,4,5]tetrazines with potential antimicrobial activity","volume":"32","author":"Shawali","year":"2009","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2019.05.081_bib7","series-title":"Selective Antibacterial Agents, Represented by 3-(azol-1-Yl)-6-Amino-Substituted 1,2,4,5-tetrazines","author":"Ishmetova","year":"2018"},{"key":"10.1016\/j.ejmech.2019.05.081_bib8","first-page":"187","article-title":"Heterocyclic systems containing bridgehead nitrogen atom. Facile synthesis and biological activity of spiro[cycloheptane-1,7'(8'H)-[6H]pyrazolo[3',4':4,5]thiazolo[3,2-b]-s-tetrazines]","volume":"15","author":"Mohan","year":"2005","journal-title":"Ind. J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.05.081_bib9","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.bmcl.2016.05.007","article-title":"Synthesis, antitumor evaluation and molecular docking studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives","volume":"26","author":"Xu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.081_bib10","article-title":"6-substituted 3-azolylimidazo[1,2-b][1,2,4,5]tetrazines showing anticancer activity","volume":"2527258","author":"Bekker","year":"2014","journal-title":"Patent RU"},{"key":"10.1016\/j.ejmech.2019.05.081_bib11","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1039\/C7CS00184C","article-title":"Inverse electron demand Diels-Alder reactions in chemical biology","volume":"46","author":"Oliveira","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2019.05.081_bib12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/acs.accounts.8b00062","article-title":"Advances in tetrazine bioorthogonal chemistry driven by the synthesis of novel tetrazines and dienophiles","volume":"51","author":"Wu","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.05.081_bib13","article-title":"Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases","volume":"2462466","author":"Bekker","year":"2012","journal-title":"Patent RU"},{"key":"10.1016\/j.ejmech.2019.05.081_bib14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s11172-014-0613-8","article-title":"Synthesis and tuberculostatic activity of amine-substituted 1,2,4,5-tetrazines and pyridazines","volume":"63","author":"Ishmetova","year":"2014","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2019.05.081_bib15","series-title":"Selective anti-tuberculosis agents, representing 3-aminosubstituted 6-(3,5-dimethylpyrazol-1-yl)-1,2,4,5-tetrazines","author":"Rusinov","year":"2014"},{"key":"10.1016\/j.ejmech.2019.05.081_bib16","article-title":"Selective antituberculosis agent representing 3-hydrazono-6-(3,5-dimethylpyrazol-1-yl)- 1,2,4,5-tetrazine and method for preparing it","volume":"2479311","author":"Rusinov","year":"2013","journal-title":"Patent RU"},{"key":"10.1016\/j.ejmech.2019.05.081_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11094-005-0068-1","article-title":"Synthesis and tuberculostatic activity of some substituted amino acid methyl esters with sym-tetrazine moieties","volume":"39","author":"Rusinov","year":"2005","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2019.05.081_bib18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1007\/s11172-015-1124-y","article-title":"Synthesis and antifungal activity of 3-substituted imidazo[1,2-b][1,2,4,5]tetrazines","volume":"64","author":"Ishmetova","year":"2015","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2019.05.081_bib19","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s11172-018-2281-6","article-title":"Synthesis and reactions of 7-phenylimidazo[1,2-b][1,2,4,5]tetrazines with nucleophiles","volume":"67","author":"Ganebnykh","year":"2018","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2019.05.081_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11172-011-0155-2","article-title":"Reactions of 1,2,4,5-tetrazines with S-nucleophiles","volume":"60","author":"Tolshchina","year":"2011","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2019.05.081_bib21","article-title":"Test system of Mycobacterium smegmatis aphVIII+ for screening of inhibitors of serine-threonine protein kinases of eukaryotic type","volume":"2566998","author":"Bekker","year":"2015","journal-title":"Patent RU"},{"key":"10.1016\/j.ejmech.2019.05.081_bib22","first-page":"1","article-title":"Synthesis and activity of (+)-usnic acid and (\u2212)-usnic acid derivatives containing 1,3-thiazole cycle against Mycobacterium tuberculosis","author":"Bekker","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.05.081_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.24075\/brsmu.2017-01-04","article-title":"Aminopyridine- and aminopyrimidine-based serine\/threonine protein kinase inhibitors are drug candidates for treating drug-resistant tuberculosis","author":"Maslov","year":"2017","journal-title":"Bull. RSMU"},{"key":"10.1016\/j.ejmech.2019.05.081_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M111.302588","article-title":"The mycobacterial transcriptional regulator whiB7 gene links redox homeostasis and intrinsic antibiotic resistance","volume":"287","author":"Burian","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.05.081_bib25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","article-title":"Mutation frequencies and antibiotic resistance","volume":"44","author":"Martinez","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.081_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkt364","article-title":"Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis","volume":"69","author":"McGrath","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.05.081_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A\u00a0diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.081_bib28","series-title":"Mycobacteria Protocols","first-page":"317","article-title":"Isolation and characterization of compound-resistant isolates of Mycobacterium tuberculosis","author":"O'Malley","year":"2015"},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2019.05.081_bib29","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/jis191","article-title":"Strategies and challenges involved in the discovery of new chemical entities during early-stage tuberculosis drug discovery","volume":"205","author":"Coxon","year":"2012","journal-title":"J.\u00a0Infect. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:54:21Z","timestamp":1759326861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419304994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":29,"alternative-id":["S0223523419304994"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.081","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}